文献速递产科母胎医学

后续发生妊娠期糖尿病和妊娠期高血压疾病女性妊娠中期的心血管表型:比较研究

Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

前瞻性观察研究纳入5214例妊娠19+1至23+3周孕妇,比较后续发生妊娠期糖尿病(GDM)和/或妊娠期高血压疾病(HDP)者与未患病者的心血管表型。HDP组(伴或不伴GDM)存在胎盘形成受损和外周血流阻抗增加;无HDP的GDM组胎盘功能正常,外周阻抗仅轻度增加或与正常无显著差异。两组均有左心室功能轻度亚临床减低。

要点

  • HDP组(伴或不伴GDM)胎盘生长因子降低,外周血流阻抗指标一致升高。
  • 无HDP的GDM组胎盘功能正常,眼动脉PSV比值与未患病组无显著差异。
  • HDP组和GDM组均出现整体纵向收缩应变增加,提示左心室功能轻度亚临床减低。

核心结论

  • 妊娠中期后续发生HDP或GDM的女性存在左心室功能轻度亚临床减低。
  • HDP组(伴或不伴GDM)有胎盘形成受损证据,外周血流阻抗生物标志物一致升高。
  • 无HDP的GDM组胎盘功能生物标志物正常,外周血流阻抗生物标志物轻度升高或与正常妊娠无显著差异。

研究设计与样本

  • 前瞻性观察研究,纳入妊娠19+1至23+3周常规医院就诊孕妇。
  • 评估眼动脉血流速度波形、超声心动图 maternal 心血管功能、子宫动脉搏动指数及血清胎盘生长因子(PlGF)。
  • 指标经母体特征和病史调整后转换为中位数倍数(MoM)或偏离中位数(delta)值,用95%CI和t检验比较GDM组、HDP组与未患病组。
  • 研究人群5214例妊娠:未患病4429例(84.9%),GDM无HDP 509例(9.8%),GDM合并HDP 41例(0.8%),HDP无GDM 235例(4.5%)。

主要发现

  • HDP组(伴或不伴GDM)PlGF降低,眼动脉收缩期峰值流速(PSV)比值、超声心动图评估的外周血管阻力和平均动脉压升高。
  • 无HDP的GDM组胎盘灌注和功能无改变证据,眼动脉PSV比值与未患病组无显著差异。
  • 无HDP的GDM组外周血管阻力和平均动脉压升高,但程度低于HDP组。
  • HDP组整体纵向收缩应变增加,等容舒张时间轻度延长。
  • GDM组二尖瓣E/e'、心肌做功指数和整体纵向收缩应变增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Women with gestational diabetes mellitus (GDM) and/or hypertensive disorders of pregnancy (HDP) are at increased long-term cardiovascular risk. Mild cardiac functional alterations have been detected in women with GDM or HDP in midgestation, prior to clinical onset of the disease, but these functional alterations have not been found to be useful as screening tools. In contrast, increased impedance to peripheral blood flow, measured by echocardiography or ophthalmic artery Doppler, has been shown to provide incremental value to maternal characteristics for the prediction of pre-eclampsia. However, it is unknown whether similar changes can be detected in women at risk of GDM. In this study, we performed detailed cardiovascular phenotyping in a large, unselected population of women in midgestation to identify similarities and differences in cardiovascular adaptation in women who are at risk of GDM and/or HDP. METHODS: This was a prospective observational study in women attending for a routine hospital visit at 19 + 1 to 23 + 3 weeks' gestation. This visit included assessment of flow velocity waveforms from the maternal ophthalmic arteries, echocardiography for assessment of maternal cardiovascular function and measurement of uterine artery pulsatility index and serum placental growth factor (PlGF) for assessment of placental perfusion and function. The measured indices were converted to either multiples of the median (MoM) values or deviation from the median (delta) after adjusting for maternal characteristics and elements of medical history. Biomarker delta or MoM values in the GDM and HDP groups were compared with those in the unaffected group using 95% CI and t-tests. RESULTS: The study population of 5214 pregnancies contained 4429 (84.9%) that were unaffected by GDM or HDP, 509 (9.8%) complicated by GDM without HDP, 41 (0.8%) with GDM and HDP, and 235 (4.5%) with HDP without GDM. In HDP cases, with or without GDM, there was evidence of impaired placentation, with a decrease in PlGF, and increased impedance to flow in the peripheral circulation, suggested by an increase in ophthalmic artery peak systolic velocity (PSV) ratio, peripheral vascular resistance assessed on echocardiography and mean arterial pressure. In the GDM group without HDP, there was no evidence of altered placental perfusion or function and ophthalmic artery PSV ratio was not significantly different from that in the unaffected group; peripheral vascular resistance and mean arterial pressure were increased but to a lesser degree than in the HDP group. In the HDP group, there was an increase in global longitudinal systolic strain and slight increase in isovolumic relaxation time, while in the GDM group, there was an increase in mitral valve E/e', myocardial performance index and global longitudinal systolic strain. CONCLUSIONS: In midgestation, women who subsequently develop HDP or GDM have a mild subclinical reduction in left ventricular function. In HDP cases, with or without GDM, there is evidence of impaired placentation and all biomarkers of impedance to peripheral blood flow are consistently increased. In contrast, in the GDM group without HDP, biomarkers of placental function are normal and those of impedance to peripheral blood flow are either marginally increased or not significantly different from those in normal pregnancies. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Anzoategui S, Gibbone E, Wright A, et al. Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study. Ultrasound Obstet Gynecol. 2022. PMID: 35502146. doi:10.1002/uog.24929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。